Penn has an established track record of patient survival. It is one of nine centers of excellence that are participants in the National Institute of Health-sponsored Adult-to-Adult Living Donor Liver Transplant consortium (A2ALL) that explores outcomes in living donor transplantation.
Penn was the first transplant institute in the region to perform an adult-to-adult living liver transplant.
As leading experts, Penn transplant surgeons and physicians have published numerous articles about living donor transplantation. They perform ground-breaking research regarding liver regeneration, minimization of immunosuppression medications in recipients and long-term quality of life for donors.
Patients who choose Penn for their transplant surgery have access to exceptional care that includes:
- A multidisciplinary team approach. Our team includes experts in surgery, hepatology, psychiatry, and transplant immunology.
- The highest level of hospitality. The Clyde F. Barker Penn Transplant House, a beautiful guest house, provides accommodations for patients and their families and caregivers.
- Innovative strategies. Penn transplant specialists are directly involved in continuously shaping U.S. transplant policy and continue to develop innovative strategies to improve outcomes for patients.